The modified prostate health index (PHI) outperforms PHI density in the detection of clinical prostate cancer within the PSA grey zone.

Haojie ChenBowen ShiYanyuan WuYuhang QianJiatong ZhouXi ZhangJie DingYongjiang Yu

Published in: International urology and nephrology (2022)

According to our present single-center experience, the mPHI-2 risk predictor outperformed PHID or other classical parameters alone in the PCa detection with a grey zone PSA level in Asian males.

Keyphrases

prostate cancer
radical prostatectomy
loop mediated isothermal amplification
white matter
healthcare
label free
real time pcr
public health
multiple sclerosis
risk assessment
quantum dots